Current Understanding of the Role of Complement in IgA Nephropathy
Top Cited Papers
- 1 July 2015
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 26 (7), 1503-1512
- https://doi.org/10.1681/asn.2014101000
Abstract
Complement activation has a role in the pathogenesis of IgA nephropathy, an autoimmune disease mediated by pathogenic immune complexes consisting of galactose-deficient IgA1 bound by antiglycan antibodies. Of three complement-activation pathways, the alternative and lectin pathways are involved in IgA nephropathy. IgA1 can activate both pathways in vitro, and pathway components are present in the mesangial immunodeposits, including properdin and factor H in the alternative pathway and mannan-binding lectin, mannan-binding lectin-associated serine proteases 1 and 2, and C4d in the lectin pathway. Genome-wide association studies identified deletion of complement factor H-related genes 1 and 3 as protective against the disease. Because the corresponding gene products compete with factor H in the regulation of the alternative pathway, it has been hypothesized that the absence of these genes could lead to more potent inhibition of complement by factor H. Complement activation can take place directly on IgA1-containing immune complexes in circulation and/or after their deposition in the mesangium. Notably, complement factors and their fragments may serve as biomarkers of IgA nephropathy in serum, urine, or renal tissue. A better understanding of the role of complement in IgA nephropathy may provide potential targets and rationale for development of complement-targeting therapy of the disease.Keywords
This publication has 109 references indexed in Scilit:
- C3 glomerulopathy–associated CFHR1 mutation alters FHR oligomerization and complement regulationJCI Insight, 2013
- Determining the Population Frequency of the CFHR3/CFHR1 Deletion at 1q32PLOS ONE, 2013
- Recent insights into C3 glomerulopathyNephrology Dialysis Transplantation, 2013
- Dimerization of complement factor H-related proteins modulates complement activation in vivoProceedings of the National Academy of Sciences of the United States of America, 2013
- Transglutaminase is essential for IgA nephropathy development acting through IgA receptorsThe Journal of Experimental Medicine, 2012
- Genome-wide association study identifies susceptibility loci for IgA nephropathyNature Genetics, 2011
- Complement: a key system for immune surveillance and homeostasisNature Immunology, 2010
- Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndromeBlood, 2010
- Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneityJCI Insight, 2009
- Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndromeJournal of Medical Genetics, 2006